FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200802016> ?p ?o ?g. }

• W3200802016 endingPage "1038" @default.
• W3200802016 startingPage "1038" @default.
• W3200802016 abstract "Staphylococcus aureus is one of the most notorious Gram-positive bacteria with a very high mortality rate. The WHO has listed S. aureus as one of the ESKAPE pathogens requiring urgent research and development efforts to fight against it. Yet there is a major layback in the advancement of effective vaccines against this multidrug-resistant pathogen. SdrD and SdrE proteins are attractive immunogen candidates as they are conserved among all the strains and contribute specifically to bacterial adherence to the host cells. Furthermore, these proteins are predicted to be highly antigenic and essential for pathogen survival. Therefore, in this study, using the immunoinformatics approach, a novel vaccine candidate was constructed using highly immunogenic conserved T-cell and B-cell epitopes along with specific linkers, adjuvants, and consequently modeled for docking with human Toll-like receptor 2. Additionally, physicochemical properties, secondary structure, disulphide engineering, and population coverage analysis were also analyzed for the vaccine. The constructed vaccine showed good results of worldwide population coverage and a promising immune response. For evaluation of the stability of the vaccine-TLR-2 docked complex, a molecular dynamics simulation was performed. The constructed vaccine was subjected to in silico immune simulations by C-ImmSim and Immune simulation significantly provided high levels of immunoglobulins, T-helper cells, T-cytotoxic cells, and INF-γ. Lastly, upon cloning, the vaccine protein was reverse transcribed into a DNA sequence and cloned into a pET28a (+) vector to ensure translational potency and microbial expression. The overall results of the study showed that the designed novel chimeric vaccine can simultaneously elicit humoral and cell-mediated immune responses and is a reliable construct for subsequent in vivo and in vitro studies against the pathogen." @default.
• W3200802016 created "2021-09-27" @default.
• W3200802016 creator A5004767231 @default.
• W3200802016 creator A5032562359 @default.
• W3200802016 creator A5047666431 @default.
• W3200802016 creator A5048925394 @default.
• W3200802016 creator A5049036315 @default.
• W3200802016 creator A5056574848 @default.
• W3200802016 creator A5056691292 @default.
• W3200802016 creator A5064369070 @default.
• W3200802016 creator A5085273502 @default.
• W3200802016 creator A5085725866 @default.
• W3200802016 date "2021-09-18" @default.
• W3200802016 modified "2023-10-16" @default.
• W3200802016 title "Development of a Conserved Chimeric Vaccine for Induction of Strong Immune Response against Staphylococcus aureus Using Immunoinformatics Approaches" @default.
• W3200802016 cites W1503364994 @default.
• W3200802016 cites W1811025669 @default.
• W3200802016 cites W1851166303 @default.
• W3200802016 cites W1902372910 @default.
• W3200802016 cites W1969932115 @default.
• W3200802016 cites W1977267470 @default.
• W3200802016 cites W1986191025 @default.
• W3200802016 cites W1990638298 @default.
• W3200802016 cites W1992192767 @default.
• W3200802016 cites W1995105203 @default.
• W3200802016 cites W2001476529 @default.
• W3200802016 cites W2014274241 @default.
• W3200802016 cites W2015176909 @default.
• W3200802016 cites W2020719323 @default.
• W3200802016 cites W2021404432 @default.
• W3200802016 cites W2035240910 @default.
• W3200802016 cites W2050600340 @default.
• W3200802016 cites W2057021995 @default.
• W3200802016 cites W2060079863 @default.
• W3200802016 cites W2090176460 @default.
• W3200802016 cites W2098533519 @default.
• W3200802016 cites W2100033891 @default.
• W3200802016 cites W2102367710 @default.
• W3200802016 cites W2102993309 @default.
• W3200802016 cites W2107379480 @default.
• W3200802016 cites W2108661081 @default.
• W3200802016 cites W2110481642 @default.
• W3200802016 cites W2115167726 @default.
• W3200802016 cites W2117985595 @default.
• W3200802016 cites W2127635589 @default.
• W3200802016 cites W2142529984 @default.
• W3200802016 cites W2150491739 @default.
• W3200802016 cites W2150923940 @default.
• W3200802016 cites W2156502117 @default.
• W3200802016 cites W2159591337 @default.
• W3200802016 cites W2162517282 @default.
• W3200802016 cites W2168481866 @default.
• W3200802016 cites W2190008860 @default.
• W3200802016 cites W2562930371 @default.
• W3200802016 cites W2572080171 @default.
• W3200802016 cites W2607286972 @default.
• W3200802016 cites W2607377760 @default.
• W3200802016 cites W2744401611 @default.
• W3200802016 cites W2782788794 @default.
• W3200802016 cites W2791228003 @default.
• W3200802016 cites W2801310097 @default.
• W3200802016 cites W2810178004 @default.
• W3200802016 cites W2910071029 @default.
• W3200802016 cites W2912818999 @default.
• W3200802016 cites W2919360226 @default.
• W3200802016 cites W2950996393 @default.
• W3200802016 cites W2979805180 @default.
• W3200802016 cites W2982625519 @default.
• W3200802016 cites W2995055934 @default.
• W3200802016 cites W2998723863 @default.
• W3200802016 cites W3024570138 @default.
• W3200802016 cites W3082799465 @default.
• W3200802016 cites W3108175496 @default.
• W3200802016 cites W3119878768 @default.
• W3200802016 cites W3135592426 @default.
• W3200802016 cites W3198484206 @default.
• W3200802016 cites W3198586799 @default.
• W3200802016 cites W4244736178 @default.
• W3200802016 cites W756891800 @default.
• W3200802016 doi "https://doi.org/10.3390/vaccines9091038" @default.
• W3200802016 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8470666" @default.
• W3200802016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34579274" @default.
• W3200802016 hasPublicationYear "2021" @default.
• W3200802016 type Work @default.
• W3200802016 sameAs 3200802016 @default.
• W3200802016 citedByCount "22" @default.
• W3200802016 countsByYear W32008020162021 @default.
• W3200802016 countsByYear W32008020162022 @default.
• W3200802016 countsByYear W32008020162023 @default.
• W3200802016 crossrefType "journal-article" @default.
• W3200802016 hasAuthorship W3200802016A5004767231 @default.
• W3200802016 hasAuthorship W3200802016A5032562359 @default.
• W3200802016 hasAuthorship W3200802016A5047666431 @default.
• W3200802016 hasAuthorship W3200802016A5048925394 @default.
• W3200802016 hasAuthorship W3200802016A5049036315 @default.
• W3200802016 hasAuthorship W3200802016A5056574848 @default.
• W3200802016 hasAuthorship W3200802016A5056691292 @default.
• W3200802016 hasAuthorship W3200802016A5064369070 @default.

• next